We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,007

El Tribunal de Justicia y la fijación unitaria de precios de medicamentos
  • Cuatrecasas Gonçalves Pereira
  • Germany
  • November 4 2016

La Sala Primera del Tribunal de Justicia ha analizado en su reciente Sentencia la normativa alemana sobre la fijación de precios uniformes para la

Acute impact decision on descriptive additions to pharmaceutical brand names
  • Latham & Watkins LLP
  • Germany
  • August 8 2013

The Higher Administrative Court of Northrhine-Westphalia (Oberverwaltungsgericht NRW OVG-NRW) has upheld a decision by the Administrative Court of

Update on recent case law restricting advertising of medicinal products
  • Baker McKenzie
  • Germany
  • February 6 2015

Recent court decisions confirm the rigorous standard ("Strengeprinzip") applied by German courts when analyzing whether or not health claims in

Price fixing not justified to protect pharmacies in rural areas
  • Bryan Cave LLP
  • European Union, Germany
  • October 26 2016

On 19 October 2016, the Court of Justice of the European Union (CJEU) issued an important judgment concerning the German law on fixing prices of

Member States cannot impose uniform retail prices for prescription-only medicinal products, highest EU Court says
  • White & Case LLP
  • European Union, Germany
  • October 21 2016

EU law precludes national legislation setting fixed retail prices for prescription medicinal products, as it unreasonably restricts imports On 19

What does “bekömmlich” mean? (easily digestible)
  • Schoenherr
  • European Union, Germany
  • July 1 2013

Regulation (EC) No 19242006 (Health Claims Regulation) prohibits health claims unless they comply with the general and specific requirements of the

German fixed price system infringes EU
  • Clifford Chance LLP
  • European Union, Germany
  • October 21 2016

With today's judgment the European Court of Justice ("ECJ") has ruled that the German fixed price system for prescription-only medicinal products

Los genéricos y las empresas que les suministran: nueva cuestión prejudicial
  • Abril Abogados
  • European Union, Germany
  • February 22 2014

El tribunal superior de justicia de Dusseldorf (Alemania) ha elevado cuestion prejudicial al Tribunal de Justicia sobre la relacion

Not all Bolar exemptions are the same - an update
  • Taylor Wessing
  • European Union, Germany, United Kingdom
  • September 26 2014

The 'regulatory review' defence, better known as the 'Bolar exemption' after a similar provision in US law, first came into force in October 2005

German Federal Supreme Court on whether therapy-related instructions may contribute to patentability in case of a claim directed to a substance for use in therapeutic treatment (decisions of February 25, 2014 Cases X ZB 513 and X ZB 613 Collagenase
  • BARDEHLE PAGENBERG Partnerschaft mbB
  • Germany
  • July 14 2014

Therapy-related instructions ("therapiebezogene Anweisungen") may contribute to patentability if they objectively aim at allowing, enhancing